Item 5.02
중요
임원 변동
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program
At the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Edwards Lifesciences Corporation, a Delaware Corporation (the “Company”), the Company’s stockholders approved the amendment and restatement of the Company’s Long-Term Stock Incentive ...
Item 5.07
주주총회 안건
에드워즈 라이프사이언시스는 2026년 5월 7일 주주총회에서 9명의 이사 선임(찬성률 94-98%), 경영진 보상 승인(찬성률 89%), 회계감사인 재임명(찬성률 89%), 장기주식보상제도 개정안 승인(찬성률 96%)을 의결했다.